Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy

Circulation

Volumn 105, Issue 12, 2002, Pages 1407-1411

  Sachdev, B ^a   Takenaka, T ^a   Teraguchi, H ^a   Tei, C ^a   Lee, P ^a   McKenna, W J ^a   Elliott, P M ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anderson Fabry disease; Cardiomyopathy; Hypertrophy

Indexed keywords

ALPHA GALACTOSIDASE;

ADOLESCENT; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME REPLACEMENT; FABRY DISEASE; GENE MUTATION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART PALPITATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SYNCOPE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ALPHA-GALACTOSIDASE; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; COHORT STUDIES; COMORBIDITY; DNA MUTATIONAL ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FABRY DISEASE; GREAT BRITAIN; HUMANS; JAPAN; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREVALENCE; REFERRAL AND CONSULTATION;

EID: 0037177166     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000012626.81324.38     Document Type: Article

References (13)

1. The management of hypertrophic cardiomyopathy
2. An atypical variant of Fabry's disease in men with left ventricular hypertrophy
3. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide angle two-dimensional echocardiographic study of 125 patients
4. Sequence variations in the first exon of alpha-galactosidase A
5. Mutational analysis in patients with the typical form of Anderson-Fabry disease
6. A point-score system for the ECG diagnosis of left ventricular hypertrophy
7. α-galactosidase, a deficiency: Fabry disease
8. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA Study
9. New insights in cardiac structural changes in patients with Fabry's disease
10. Hypertrophic cardiomyopathy: The importance of the site and extent of hypertrophy: A review
11. Electrocardiographic findings in patients with obstructive and non-obstructive hypertrophic cardiomyopathy
12. Enzyme replacement therapy in Fabry disease: A randomized controlled trial
13. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease